|
- Prostate cancer: diagnosis and management | Guidance - NICE
This guideline covers the diagnosis and management of prostate cancer in secondary care, including information on the best way to diagnose and identify different stages of the disease, and how to manage adverse effects of treatment It also includes recommendations on follow-up in primary care for
- Prostate cancer: diagnosis and management - NICE
This guideline covers the diagnosis and management of prostate cancer in secondary care, including information on the best way to diagnose and identify different stages of the disease, and how to manage adverse effects of treatment It also includes recommendations on follow-up in primary care for people diagnosed with prostate cancer
- NG131 Prostate cancer: diagnosis and treatment - full guideline - NICE
May 2021: Links added to the NICE Pathway on prostate cancer for information on our technology appraisal guidance, including genomic biomarker-based therapy in solid tumour treatment pathways November 2020: We corrected the unit of measurement for PSA velocity to nanogram ml year in recommendations 1 2 11 and 1 2 12
- Assessment | Diagnosis | Prostate cancer | CKS | NICE
DRE allows assessment of the prostate for signs of prostate cancer (a hard gland, sometimes with palpable nodules) or benign enlargement (smooth, firm, enlarged gland) It is important to note that the DRE sensitivity for prostate cancer has been shown to be very poor in the absence of a raised prostatic-specific antigen test
- 3 Guideline - NICE
3 Guideline 4 Prostate cancer: diagnosis and management 5 Draft for consultation, October 2021 6 This is an update to NICE guideline NG131 (published May 2019) We have:
- Scenario: Management | Management | Prostate cancer | CKS | NICE
The Predict Prostate patient decision aid is endorsed by NICE and supports the NICE guideline on prostate cancer Produced by the University of Cambridge Academic Urology Group, it compares the potential outcomes of different treatment options for people with non-metastatic prostate cancer
- Suspected cancer: recognition and referral | Guidance - NICE
This guideline covers identifying children, young people and adults with symptoms that could be caused by cancer It outlines appropriate investigations in primary care, and selection of people to refer for a specialist opinion It aims to help people understand what to expect if they have symptoms
- Prostate cancer | Topic | NICE
All NICE products on prostate cancer Includes any guidance, advice and quality standards
|
|
|